NIPER Mohali and Novartis Healthcare Sign Agreement to Advance Pharmaceutical Research

The National Institute of Pharmaceutical Education and Research (NIPER), Mohali, has signed a Development Pioneer Grant agreement with Novartis Healthcare Private Limited to strengthen pharmaceutical research and innovation in India. The collaboration aims to support faculty-led research initiatives, enhance industry–academia engagement, and accelerate the development of advanced pharmaceutical solutions. The agreement was formalised in the presence of senior officials from the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.

Industry–Academia Collaboration Boost

This partnership is designed to bridge the gap between academic research and industry applications by enabling structured collaboration between researchers and a global pharmaceutical leader. It is expected to provide access to advanced research frameworks, improve knowledge exchange, and support innovation-driven projects within India’s pharmaceutical education ecosystem. Such initiatives strengthen India’s position as a growing hub for drug discovery and life sciences research.

Strengthening India’s Pharma Innovation Ecosystem

The agreement reflects a broader industry trend of global pharma companies investing in Indian research institutions to build long-term innovation capabilities. By supporting early-stage research and translational science, the collaboration is likely to enhance the pipeline of new drug development and improve commercialization opportunities for academic innovations. It also aligns with national efforts to boost self-reliance in pharmaceutical R&D.